Work

Cost-Effectiveness of Once-Daily Oral Chelation Therapy with Deferasirox (Exjade®, ICL670) Versus Infusional Deferoxamine in Transfusion-Dependent Thalassemic Patients.

Year: 2005

Type: article

Source: Blood

DOI: 10.1182/blood.v106.11.1341.1341

Authors: Thomas E. Delea, Oleg Sofrygin, Simu K. Thomas, Jean-Francois Baladi, Pradyumna D. Phatak, Thomas D. Coates

Institutions: Policy Analysis (United States), Rochester General Hospital, Children's Hospital Los Angeles

Language: English

Topic: Hemoglobinopathies and Related Disorders

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2510383347

FWCI: 0.148

Cites:

Cited by: 2

Related to: 10